Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

Published on 14 Nov 2024 on The Motley Fool · via AOL

Down” alerts for three incredible companies, and there may not be another chance like this anytime...

Read the rest of the article

Start tracking your investments with Statfolio

(Bloomberg) -- A revival in AstraZeneca Plc shares faces a key test this week, with more likely t...

Bloomberg · via Yahoo Finance 3 Feb 2025

(Bloomberg) -- Stocks are ending a wild week on a positive note after solid forecasts from tech...

Bloomberg · via Yahoo Finance 31 Jan 2025

AstraZeneca PLC (LON:AZN), a leading global biopharmaceutical company with a market capitalizatio...

Investing.com 30 Jan 2025

(Bloomberg) -- Sanofi said it will repurchase €5 billion ($5.2 billion) of stock and grow profits...

Bloomberg · via Yahoo Finance 30 Jan 2025

Astrazeneca (AZN) AstraZeneca plc, headquartered in London, UK, is one of the largest biopharmace...

Zacks · via Yahoo Finance 29 Jan 2025

This AZN drug is currently approved for two indications, namely eosinophilic asthma and EGPA....

Zacks · via Yahoo Finance 29 Jan 2025

In the first nine months of 2024, Enhertu generated $1.05 billion in alliance revenues for...

Zacks · via Yahoo Finance 28 Jan 2025

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article...

Insider Monkey · via Yahoo Finance 22 Jan 2025

The FDA's nod is based on late-stage data, which show AZN's Datroway cuts the risk of disease...

Zacks · via Yahoo Finance 20 Jan 2025

This investing style is all about taking advantage of upward or downward trends in a stock's pric...

Zacks · via Yahoo Finance 20 Jan 2025